{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:53:25Z","timestamp":1788872005837,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"crossref","award":["DMR-101-053"],"award-info":[{"award-number":["DMR-101-053"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"crossref","award":["DMR-100-166"],"award-info":[{"award-number":["DMR-100-166"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Buddhist Tzu Chi General Hospital","award":["TTCRD-10011"],"award-info":[{"award-number":["TTCRD-10011"]}]},{"name":"Taiwan Department of Health Clinical Trial and Research Center of Excellence","award":["DOH100-TD-B-111-004"],"award-info":[{"award-number":["DOH100-TD-B-111-004"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental and Toxicologic Pathology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.etp.2012.09.003","type":"journal-article","created":{"date-parts":[[2012,10,12]],"date-time":"2012-10-12T17:26:15Z","timestamp":1350062775000},"page":"703-708","source":"Crossref","is-referenced-by-count":0,"title":["The potential use of primary human upper urinary tract urothelial cell carcinoma (UUT-UCC) cultured cells for prognostic indicators and chemosensitivity test"],"prefix":"10.1016","volume":"65","author":[{"given":"Teng-Fu","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Hsiang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Lin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Lung","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Rong","family":"Shyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.etp.2012.09.003_bib0005","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1200\/JCO.2004.09.043","article-title":"Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group","volume":"22","author":"Bamias","year":"2004","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.etp.2012.09.003_bib0010","first-page":"465","article-title":"Primary prostate cancer cultures are models for androgen-independent transit amplifying cells","volume":"23","author":"Buhler","year":"2010","journal-title":"Oncology Reports"},{"key":"10.1016\/j.etp.2012.09.003_bib0015","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.juro.2007.01.030","article-title":"Behavior of urothelial carcinoma with respect to anatomical location","volume":"177","author":"Catto","year":"2007","journal-title":"Journal of Urology"},{"key":"10.1016\/j.etp.2012.09.003_bib0020","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/path.1711680404","article-title":"Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections","volume":"168","author":"Cattoretti","year":"1992","journal-title":"Journal of Pathology"},{"key":"10.1016\/j.etp.2012.09.003_bib0025","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0022-5347(17)35473-3","article-title":"Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors","volume":"150","author":"Eastham","year":"1993","journal-title":"Journal of Urology"},{"key":"10.1016\/j.etp.2012.09.003_bib0030","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0090-4295(98)00295-7","article-title":"Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients","volume":"52","author":"Hall","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.etp.2012.09.003_bib0035","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/jcp.46.12.1080","article-title":"New antiserum against Ki-67 antigen suitable for double immunostaining of paraffin wax sections","volume":"46","author":"Key","year":"1993","journal-title":"Journal of Clinical Pathology"},{"key":"10.1016\/j.etp.2012.09.003_bib0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.urology.2006.01.053","article-title":"Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract","volume":"68","author":"Kwak","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.etp.2012.09.003_bib0045","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1159\/000020233","article-title":"Prognostic value of MIB-1 antibody labeling index to predict response to Bacillus Calmette-Guerin therapy in a high-risk selected population of patients with stage T1 grade G3 bladder cancer","volume":"37","author":"Lebret","year":"2000","journal-title":"European Urology"},{"key":"10.1016\/j.etp.2012.09.003_bib0050","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1158\/1078-0432.CCR-06-1472","article-title":"Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease","volume":"12","author":"Margulis","year":"2006","journal-title":"Clinical Cancer Research"},{"issue":"1877\u20131880","key":"10.1016\/j.etp.2012.09.003_bib0055","first-page":"1880","article-title":"Prognostic significance of Ki-67 labeling index in urothelial tumors of the renal pelvis and ureter","volume":"155","author":"Masuda","year":"1996","journal-title":"Journal of Urology"},{"key":"10.1016\/j.etp.2012.09.003_bib0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.pcan.4501018","article-title":"Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells","volume":"11","author":"Miki","year":"2008","journal-title":"Prostate Cancer and Prostatic Disease"},{"key":"10.1016\/j.etp.2012.09.003_bib0065","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF00191218","article-title":"The E-cadherin cell\u2013cell adhesion pathway in urologic malignancies","volume":"13","author":"Morton","year":"1995","journal-title":"World Journal of Urology"},{"key":"10.1016\/j.etp.2012.09.003_bib0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.eururo.2004.04.011","article-title":"EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma","volume":"46","author":"Oosterlinck","year":"2004","journal-title":"European Urology"},{"key":"10.1016\/j.etp.2012.09.003_bib0075","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.ju.0000107767.56680.f7","article-title":"The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract","volume":"171","author":"Park","year":"2004","journal-title":"Journal of Urology"},{"issue":"60\u201367","key":"10.1016\/j.etp.2012.09.003_bib0080","first-page":"67","article-title":"Adjuvant and neoadjuvant chemotherapy in muscle invasive bladder cancer: literature review","volume":"48","author":"Pectasides","year":"2005","journal-title":"European Urology"},{"key":"10.1016\/j.etp.2012.09.003_bib0085","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1182\/blood.V76.11.2327.2327","article-title":"In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions","volume":"76","author":"Pieters","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.etp.2012.09.003_bib0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/jcp.2004.022939","article-title":"Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder","volume":"59","author":"Quintero","year":"2006","journal-title":"Journal of Clinical Pathology"},{"key":"10.1016\/j.etp.2012.09.003_bib0095","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.eururo.2010.12.042","article-title":"European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update","volume":"59","author":"Roupret","year":"2011","journal-title":"European Urology"},{"key":"10.1016\/j.etp.2012.09.003_bib0100","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1046\/j.1442-2042.2001.00286.x","article-title":"Prophylactic intravesical instillation of mitomycin C and cytosine arabinoside for prevention of recurrent bladder tumors following surgery for upper urinary tract tumors: a prospective randomized study","volume":"8","author":"Sakamoto","year":"2001","journal-title":"International Journal of Urology"},{"key":"10.1016\/j.etp.2012.09.003_bib0105","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1083\/jcb.123.3.513","article-title":"The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins","volume":"123","author":"Schluter","year":"1993","journal-title":"Journal of Cell Biology"},{"key":"10.1016\/j.etp.2012.09.003_bib0110","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0090-4295(00)00612-9","article-title":"Continuous antegrade infusion of adriamycin as adjuvant therapy for upper tract urothelial malignancies","volume":"56","author":"See","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.etp.2012.09.003_bib0115","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0090-4295(00)00892-X","article-title":"E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder","volume":"57","author":"Shariat","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.etp.2012.09.003_bib0120","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1442-2042.2008.02114.x","article-title":"Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma","volume":"15","author":"Soga","year":"2008","journal-title":"International Journal of Urology"},{"key":"10.1016\/j.etp.2012.09.003_bib0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.anndiagpath.2003.11.007","article-title":"E-cadherin expression in invasive urothelial carcinoma","volume":"8","author":"Sun","year":"2004","journal-title":"Annals of Diagnostic Pathology"},{"key":"10.1016\/j.etp.2012.09.003_bib0130","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1242\/dev.102.4.639","article-title":"The cadherins: cell\u2013cell adhesion molecules controlling animal morphogenesis","volume":"102","author":"Takeichi","year":"1988","journal-title":"Development"},{"key":"10.1016\/j.etp.2012.09.003_bib0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0304-3835(96)04194-8","article-title":"Loss of human E-cadherin (ECD) correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter and urinary bladder","volume":"103","author":"Wakatsuki","year":"1996","journal-title":"Cancer Letters"},{"key":"10.1016\/j.etp.2012.09.003_bib0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/jcp.10281","article-title":"Primary culture model of peroxisome proliferator-activated receptor gamma activity in prostate cancer cells","volume":"196","author":"Xu","year":"2003","journal-title":"Journal of Cellular Physiology"}],"container-title":["Experimental and Toxicologic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S094029931200084X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S094029931200084X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T01:33:18Z","timestamp":1643506398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S094029931200084X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S094029931200084X"],"URL":"https:\/\/doi.org\/10.1016\/j.etp.2012.09.003","relation":{},"ISSN":["0940-2993"],"issn-type":[{"value":"0940-2993","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}